The $8-billion acquisition will broaden Lilly's oncology portfolio in precision medicines and treatments that target cancers caused by specific gene abnormalities. / read more /
Drug pricing and reimbursement concerns will continue to hinder industry growth in 2019, according to data and analytics company GlobalData. / read more /
AbbVie and immunotherapy company Tizona Therapeutics will join forces to develop and commercialize CD39-targeted therapeutics to treat cancer. / read more /
The new reagents are designed to support clinical-phase and commercialization stages of cell and gene therapy production and to enhance DNA transfection. / read more /
A required time frame should not be the driving force behind root cause investigations, says Susan Schniepp, executive vice-president of Post-Approval Pharma and Distinguished Fellow, Regulatory Compliance Associates. / read more /
Transdermal patch design, materials, and manufacturing variables, as well as drug formulation and interactions between the API and the adhesive, can affect adhesion and drug delivery. / read more /
SMA MicroParticle ICS™
VAI is pleased to announce the addition of the SMA MicroParticle ICS line of non-viable particle counters that utilize the latest innovation in particle counting technology, to our contamination control portfolio. / Read more/
Pharmapack Booth number: G102
WHEATON® Primary Packaging Solutions manufactured by SciLabware
SciLabware Limited, a company of DWK Life Sciences, is one of the world's leading manufacturers of high quality primary packaging solutions to the diagnostic and pharmaceutical industries across the globe. / Read more/
The editors explore new tools for bio/pharma lab studies—such as robotics, augmented reality, and advanced instrumentation— as well as best practices for method development, multiple attribute monitoring, lab mixers, and raw material testing.
